Abstract

Research Article

Pharmaco-economic study and cost of care for chronic diseases: Case of Haemophilia in Morocco

Khairoun C*, Khorassani M, Kili A, Hssissen L, Kababri M and Khattab M

Published: 02 April, 2020 | Volume 3 - Issue 1 | Pages: 024-026

This paper is an attempt to enrich the literature about the role that can play some economic approaches, such as cost-effectiveness analysis, in order to help medical stuffs to decide about the treatment to adopt in case of a chronic disease such as Haemophilia. Data from morocco were gathered in order to explain the importance of such approaches.

Read Full Article HTML DOI: 10.29328/journal.japch.1001013 Cite this Article Read Full Article PDF

Keywords:

Pharmaco-economic study; Cost-effectiveness analysis; Haemophilia; Prophylaxis

References

  1. Ministry of Health. National Chronic Disease Plan 2007-2011 [Internet]. 2007.
  2. World Health Organization. WHO: Chronic diseases.
  3. Carrier S, Morin P, Gross O, De La Tribonnière X. L'engagement de la personne dans les soins de santé et services sociaux: Regards croisés France-Québec: Presses de l'Université du Québec. 2017.
  4. https://www.mloz.be/sites/default/files/publications/envol_cout_maladies_chroniques_0318.pdf
  5. Hemophilia B in Morocco. Current state and outlook.
  6. Emmanuil Kombarelis, willim P. J Clini Epidemiology. 2011; 47.
  7. Hay CR, Brown S, Collins PW. le diagnosticet la gestion du facteur VII et IX,Centre d'hémophilie Br, Haematol. 2006; 133: 591-605.
  8. Jenny Goudemand, Yves Laurien. 'hémophilie Orphanet Mai. 2006.
  9. Kessler CM, Goldman L. Hemmoragic disorders :coagulation factor diferences,cecil Medecine 23rd ed,Philadelphia, Sauders Elsevier. 2007; 180.
  10. Kessler CM, Mariani. manifestations cliniques et traitement de l'hémophilie,Hemostasis et Thrombosis 5èd Philadelphia. 2006; 887.
  11. Khachidz M, Buil A, Viel KR, Porter S. Genetic determinants of normal variation in coagulation factor IX. Hemostasis Thrombosis. 2006; 4: 1537-1545.
  12. Siegmund B, Richter H, Pollmann H. Need for prophylactic treatment in adult haemophilia A patients. Transfusion Medicine and Hemotherapy. 2009; 36: 283-288.
  13. Suzuki Katsuhiko. Chronic inflammation as an immunological abnormality and effectiveness of exercise. Biomolecules. 2019; 9: 223. PubMed: https://pubmed.ncbi.nlm.nih.gov/31181700/
  14. Cortesi, Paolo Angelo, Gianluca Trifirò, Simona Serao Creazzola, Giovanni Improta, et al. Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors. Thromb Haemost. 120.02 (2020): 216-228. PubMed: https://pubmed.ncbi.nlm.nih.gov/31887777/
  15. Liesner RJ, Khair K, Hann IM. The impact of prophylactic treatment on children with severe haemophilia. Br J Haematol. 1996; 92: 973-978. PubMed: https://pubmed.ncbi.nlm.nih.gov/8616096/
  16. Matsumura Risa. Pharmacokinetics of Extended Half-Life Factor VIII Products By my PKFiTR Is Useful for Personalized Treatment in Children with Severe Hemophilia a. 2019; 1127.

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

  • Clinical Severity of Sickle Cell Anaemia in Children in the Gambia: A Cross-Sectional Study
    Lamin Makalo, Samuel A Adegoke, Stephen J Allen, Bankole P Kuti, Kalipha Kassama, Sheikh Joof, Aboulie Camara, Mamadou Lamin Kijera and Egbuna O Obidike Lamin Makalo,Samuel A Adegoke,Stephen J Allen,Bankole P Kuti,Kalipha Kassama,Sheikh Joof,Aboulie Camara,Mamadou Lamin Kijera,Egbuna O Obidike. Clinical Severity of Sickle Cell Anaemia in Children in the Gambia: A Cross-Sectional Study. J Hematol Clin Res. 2025: doi: 10.29328/journal.jhcr.1001033; 9: 001-006
  • Prospective evaluation of a computerized algorithm for Vitamin K antagonist drug dose calculation
    Maarten J Beinema*, Jacobus RBJ Brouwers, Henk Adriaansen and Frank GA Jansman Maarten J Beinema*,Jacobus RBJ Brouwers,Henk Adriaansen,Frank GA Jansman. Prospective evaluation of a computerized algorithm for Vitamin K antagonist drug dose calculation. J Hematol Clin Res. 2023: doi: 10.29328/journal.jhcr.1001020; 7: 001-005
  • Systemic sclerosis sine scleroderma presenting as renal crisis, a case report and review of the literature
    Urvi V Patel, Navdeep Sangha* and Andrew Rettew Urvi V Patel, Navdeep Sangha*, Andrew Rettew. Systemic sclerosis sine scleroderma presenting as renal crisis, a case report and review of the literature. J Hematol Clin Res. 2023: doi: 10.29328/journal.jhcr.1001021; 7: 001-010
  • Mechanism of Small Molecule Inhibitors of Phagocytosis
    Melika Loriamini, Melissa M Lewis-Bakker, Beth Binnington, Lakshmi P Kotra and Donald R Branch* Melika Loriamini, Melissa M Lewis-Bakker, Beth Binnington, Lakshmi P Kotra, Donald R Branch*. Mechanism of Small Molecule Inhibitors of Phagocytosis. J Hematol Clin Res. 2023: doi: 10.29328/journal.jhcr.1001022; 7: 011-014
  • Evaluation of the Bone Marrow Aspirate Examination Practice at the University Hospital Andrainjato Fianarantsoa, Madagascar
    Bronislaw Tchestérico Dodoson, Jocia Fenomanana, Manevarivo Eddy Ramaminiaina, Stéphania Niry Manantsoa, Zely Arivelo Randriamanantany, Andriamiadana Luc Rakotovao and Aimée Olivat Rakoto Alson Bronislaw Tchestérico Dodoson, Jocia Fenomanana, Manevarivo Eddy Ramaminiaina, Stéphania Niry Manantsoa, Zely Arivelo Randriamanantany, Andriamiadana Luc Rakotovao, Aimée Olivat Rakoto Alson. Evaluation of the Bone Marrow Aspirate Examination Practice at the University Hospital Andrainjato Fianarantsoa, Madagascar. J Hematol Clin Res. 2023: doi: 10.29328/journal.jhcr.1001023; 7: 015-020

Read More

Most Viewed

Read More

Help ?